Efalizumab (Anti-Integrin aL / ITGAL / CD11a)
Efalizumab (Anti-Integrin aL / ITGAL / CD11a) (A2421-GRP)
Products
Description
Efalizumab (Anti-Integrin aL / ITGAL / CD11a) is a humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with immunosuppressant activity. MW: 145.5 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2421 |
| Target | CD markers |